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Monocytes  are  short-lived  cells,  arising  from  the  bone  marrow  and  maturing  in  the  circulation.  They
play  an  important  role  in  immune  responses  and  are  thought  to  be  important  for healthy  pregnancy.  In
humans,  3  subpopulations  of  monocytes  have  been  identiﬁed:  classical,  intermediate  and  non-classical
monocytes.  These  subpopulations  have  different  functions  and  phenotypical  characteristics.  Healthy
pregnancy  is  characterized  by  a pro-inﬂammatory  condition,  with  increased  numbers  of monocytes
and  monocyte  activation  as well  as  with  increased  numbers  of  intermediate  monocytes  and  decreasedonocyte subsets
regnancy
reeclampsia
at
numbers  of classical  monocytes.  This  may  suggest  monocyte  maturation.  Preeclampsia  is an  important
pregnancy  complication  characterized  by  hypertension  and  proteinuria  developing  in the second  half  of
pregnancy.  The  pathophysiology  of  preeclampsia  is associated  with  further  activation  of  the  inﬂamma-
tory  response,  further  activation  of monocytes  and  further  monocyte  maturation.  In  the  present  review
we  focus  on  the  role of monocyte  activation  and  maturation  in  healthy  and  preeclamptic  pregnancy.
© 2016  The  Authors.  Published  by  Elsevier  Ireland  Ltd.  This  is an open  access  article  under  the  CC  BY. Introduction
Pregnancy poses a unique immunological challenge to the
other. Semi-allogeneic placental tissue is in direct contact with
irculating and uterine maternal immune cells. Therefore adapta-
ions in the immune response are seen locally in the uterus and
ecidua, but also peripherally in the maternal blood (Veenstra Van
ieuwenhoven et al., 2003b). It has been suggested that the adapta-
ions of the peripheral immune response are due to the circulation
f maternal blood through the placenta and the secretion of pla-
ental factors into the maternal circulation (Sacks et al., 1999;
ellembakken et al., 2002). Adaptations in the maternal peripheral
mmune response are observed in the speciﬁc immune response,
uch as a decreased Th1/Th2 ratio in T cells (Wegmann et al.,
993; Saito et al., 1999; Veenstra Van Nieuwenhoven et al., 2002),
ncreased numbers of regulatory T cells during the ﬁrst and secondPlease cite this article in press as: Faas, M.M.,  de Vos, P., Maternal mo
Reprod. Immunol. (2016), http://dx.doi.org/10.1016/j.jri.2016.06.009
rimester of pregnancy (Saito et al., 2010; Ernerudh et al., 2011) and
n increased Treg/Th17 ratio (Figueiredo and Schumacher, 2016).
hanges are also observed in NK cells (Veenstra Van Nieuwenhoven
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165-0378/© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access license  (http://creativecommons.org/licenses/by/4.0/).
et al., 2002; Borzychowski et al., 2005). Not only cells of the adap-
tive immune response, but also cells of the innate immune system,
monocytes and granulocytes, are affected by pregnancy. They show
an activated phenotype (Sacks et al., 1998).
Preeclampsia is a major complication of the second half of preg-
nancy. It is characterized by hypertension and proteinuria (Duley,
2009; Steegers et al., 2010). The most severe form of preeclampsia,
early onset preeclampsia, is thought to arise from poor placenta-
tion (Redman and Sargent, 2009). This results in the production of
pro-inﬂammatory factors by the diseased placenta into the mater-
nal circulation (Hung et al., 2004; Levine et al., 2004; Germain
et al., 2007; Spaans et al., 2014a). Such factors may  further acti-
vate the already activated monocytes in pregnancy and together
with activation of other inﬂammatory cells, such as granulocytes
and endothelial cells, ﬁnally induce the full blown syndrome of
preeclampsia (Redman and Sargent, 2009).
The present review will focus on peripheral monocytes in preg-
nancy and preeclampsia. Changes in circulating monocytes will be
discussed as well as the role these cells may  play in the physiol-
ogy of normal pregnancy and the pathophysiology of preeclampsia.
Animal models will be discussed since they are important in under-nocytes in pregnancy and preeclampsia in humans and in rats. J.
standing the role of monocytes pregnancy and preeclampsia.
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Fig. 1. Monocytes in the utero-placental circulation.
Monocytes get into the intervillous space via the spiral arteries. In the intervillous
space they can come into direct contact with the fetal syncytiotrophoblast. The syn-
cytiotrophoblast also produces various factors into the intervillous space (and thus
into the maternal circulation), such as syncytiotrophoblast microparticles (MP) or
exosomes (exo), cytokines, antiangiogenic factors (such as sFlt-1). Such factors may
also activate monocytes in the intervillous space. Activated monocytes leave the
intervillous space via the placental veins to get into the maternal circulation.
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.1. Utero-placental circulation
The placenta is important in maternal-fetal exchange of nutri-
nts and gases. In a human placenta, which is hemochorial, this
s enabled by fetal villi bathing in maternal blood in the intervil-
ous space (Boyd JD, 2013). The placenta develops after invasion
f fetal trophoblast into the endometrium and the spiral arteries
n the endometrium starting 5–6 days after fertilization (Sadler,
004). Although, the development of the villous structure and the
ntervillous space starts early in pregnancy, the connection of the
ntervillous space with the spiral arteries does only develop after 9
eeks of pregnancy (Jauniaux et al., 2000). From that time onward,
aternal blood is in close contact with the fetal villi. This enables
asy exchange of gases and nutrients between mother and fetus,
ut also poses a challenge to the mother, since maternal immune
ells circulating through the placenta in the intervillous space
re in direct contact with fetal semi-allogeneic trophoblast cells.
his contact of maternal immune cells with the fetal trophoblast
ay  inﬂuence the maternal immune cells. Not only direct contact
etween fetal trophoblast and maternal immune cells may  inﬂu-
nce the maternal immune cells, it has also been suggested that
he trophoblast secretes many factors into the maternal circulation
hat also may  also affect the maternal immune cells. Such factors
ay be cytokines (Sacks et al., 2001), fetal DNA (Bianchi et al., 1996)
nd syncytiotrophoblast microvesicles (Redman et al., 2012) (see
ig. 1).
.2. Monocytes
Monocytes are short-lived circulating cells, which arise from
yelo-monocytic precursors in the bone marrow. They comprise
bout 5–10% of the circulating blood leukocytes and migrate into
he tissue to become macrophages and dendritic cells (Gordon
nd Taylor, 2005). They have various functions, such as phagocy-Please cite this article in press as: Faas, M.M.,  de Vos, P., Maternal mo
Reprod. Immunol. (2016), http://dx.doi.org/10.1016/j.jri.2016.06.009
osis, antigen presentation and cytokine production (Gordon and
aylor, 2005). Monocytes in the peripheral circulation have a het-
rogeneous morphology, since they can vary in size, show different
egrees of granularity and may  have different nuclear morphology PRESS
ive Immunology xxx (2016) xxx–xxx
(Gordon and Taylor, 2005). In humans, monocytes can be identiﬁed
by expression of the extracellular marker CD14, which is expressed
by all monocytes (Gordon and Taylor, 2005).
1.2.1. Monocyte subsets
In humans, three monocyte subsets exist, which can be distin-
guished based on their expression of CD14 and CD16 (FcR-III).
The main subset, the classical monocytes, representing 90–95% of
the monocytes, is a subset, which expresses high levels of CD14,
while lacking CD16 expression. Non-classical monocytes are the
second subset, which is characterized by low expression of CD14
with high expression of CD16. A third, intermediate subset of
monocytes (high CD14 expression and high CD16 expression) has
also been deﬁned (Ziegler-Heitbrock et al., 2010). It is thought
that classical monocytes arise from the bone marrow and mature
in the circulation via intermediate monocytes into non-classical
monocytes (Sunderkötter et al., 2004; Ziegler-Heitbrock et al.,
2010). The monocyte subsets differ in many aspects (Gordon and
Taylor, 2005; Ziegler-Heitbrock et al., 2010). Classical monocytes
are able to generate reactive oxygen species (ROS) and produce
cytokines after stimulation with Toll-like receptor agonists. They
are strong phagocytes. Non-classical monocytes do not gener-
ate ROS, but are more efﬁcient producers of pro-inﬂammatory
cytokines after TLR stimulation, while they are weaker phago-
cytes (Gordon and Taylor, 2005). The non-classical monocytes have
a longer half-life and inﬁltrate into resting and inﬂamed tissue
(Gordon and Taylor, 2005). They are thought to patrol and sur-
vey the endothelium and rapidly invade the tissue and initiate
the inﬂammatory response (Auffray et al., 2007; Ziegler-Heitbrock
et al., 2010). The function of intermediate monocytes is less clear
and in general they have an intermediate function between clas-
sical and non-classical monocytes (Wong et al., 2011). Based on
their high gene and protein expression of MHC  II (Wong et al.,
2011; Groen et al., 2015), they may  have an important role in anti-
gen presentation and T cell activation. Intermediate monocytes
have been shown to be increased in various inﬂammatory dis-
eases (Rogacev et al., 2012; Ziegler-Heitbrock, 2015; Wong et al.,
2012), suggesting that they play a pathophysiological role in these
diseases.
2. Maternal monocytes in pregnancy
Changes in the innate immune response are apparent during
pregnancy. Most obvious are the increased numbers of circulating
monocytes and granulocytes (Siegel and Gleicher, 1981; Kuhnert
et al., 1998; Veenstra Van Nieuwenhoven et al., 2003a). However,
not only are numbers of monocytes increased during pregnancy,
also the monocytes are activated and show functional changes.
Phenotypical activation of monocytes during pregnancy has been
shown by increased expression of the activation markers CD11b,
CD14 and CD64 on monocytes from pregnant women as compared
with monocytes from non-pregnant women (Sacks et al., 1998;
Naccasha et al., 2001; Luppi et al., 2002a,b). Functional changes
in monocytes from pregnant women have been demonstrated by
increased production of oxygen free radicals (Sacks et al., 1998)
and decreased phagocytosis in pregnancy (Lampe et al., 2015). Also
changes in cytokine production have been observed (Veenstra Van
Nieuwenhoven et al., 2003a; Faas et al., 2014a). Cytokine produc-
tion can be studied in unstimulated and stimulated monocytes.
Unstimulated monocyte cytokine production represents the in vivo
cytokine production, while stimulated monocyte cytokine produc-nocytes in pregnancy and preeclampsia in humans and in rats. J.
tion represents the ability of monocytes to respond to stimuli
in vivo. For unstimulated monocytes, results have been inconsis-
tent, since increased (Luppi et al., 2002a), decreased (Faas et al.,
2014a) or unchanged (Veenstra Van Nieuwenhoven et al., 2003a;
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ermain et al., 2007) cytokine production by non-stimulated
onocytes from pregnant women vs non-pregnant women has
een shown. These inconsistent results may  be due to differ-
nt methods of preparing monocytes and/or measuring cytokine
roduction. Monocyte cytokine production can be measured in
hole blood (Luppi et al., 2002a; Veenstra Van Nieuwenhoven
t al., 2003a; Faas et al., 2014a), after isolating peripheral blood
ononuclear cells (PBMC) (Germain et al., 2007), or after isolating
onocytes (this has never been done for pregnant women). Isola-
ion of monocytes, even a relatively mild isolation such as isolation
f PBMC, may  affect monocyte activation and therefore cytokine
roduction (Macey et al., 1995). Also the method of measuring
ytokine production may  inﬂuence the outcome. Cytokines can be
easured by ELISA (Germain et al., 2007; Faas et al., 2014a) or by
ow cytometry (Luppi et al., 2002a; Veenstra Van Nieuwenhoven
t al., 2003a). Especially for ﬂow cytometry, the choice of the anti-
odies, dilution of the antibodies, and choice of the isotype controls
s well as gate setting is extremely important and differences
etween different labs may  result in different outcomes. Changes
n unstimulated monocyte cytokine production in vitro may  be in
ine with the fact that plasma cytokine levels have changed during
regnancy (Szarka et al., 2010). It has for instance been shown that
lasma levels of IL-12 and IL-18 are increased during pregnancy
Szarka et al., 2010).
In order to study the potential of monocytes to respond to
ro-inﬂammatory stimuli, in various studies monocytes have been
timulated. Often lipopolysaccharide (LPS) has been used. After
timulation with LPS, cytokine production by monocytes from
regnant women was decreased as compared with cytokine pro-
uction by monocytes from non-pregnant women  (Veenstra Van
ieuwenhoven et al., 2003a; Beckmann et al., 2004; Faas et al.,
014a). This decreased cytokine production is not due to decreased
xpression of TLR4 (which is the main receptor for LPS) (Faas et al.,
014a). It may, however, be a sign of activation of monocytes, since
ctivated monocytes become tolerant to LPS (Faas et al., 2002). IFN
s able to abrogate LPS tolerance (Chen and Ivashkiv 2010) and
herefore, after stimulation of monocytes with both LPS and IFN,
ndotoxin tolerance can be overcome and monocytes of pregnant
omen showed increased cytokine production as compared with
onocytes from non-pregnant women after stimulation with both
PS and IFN (Sacks et al., 2003). Most of the studies on mono-
ytes during pregnancy have been performed in the third trimester
f pregnancy and based on all above-mentioned data, it is now
enerally accepted that monocytes are activated during pregnancy.
nfortunately, not many studies have evaluated monocyte activa-
ion during the course of pregnancy. One study showed progressive
henotypical activation of monocytes from the ﬁrst trimester to the
hird trimester (Luppi et al., 2002a).
.1. Monocyte subsets in pregnancy
Although it has been known for more than a decade that mono-
ytes are a heterogeneous population, studies on monocytes in
regnancy as presented above have mainly been performed on
lassical monocytes. Since intermediate monocytes are increased
n inﬂammatory diseases, we hypothesized that this monocyte
ubset would also be increased in pregnancy. We  thus conducted
wo studies in which we identiﬁed the 3 subsets of monocytes
n pregnant women (Melgert et al., 2012; Groen et al., 2015). In
ine with our hypothesis, during healthy pregnancy we showed
n increased number of intermediate monocytes and a decreased
umber of classical monocytes (Melgert et al., 2012; Groen et al.,Please cite this article in press as: Faas, M.M.,  de Vos, P., Maternal mo
Reprod. Immunol. (2016), http://dx.doi.org/10.1016/j.jri.2016.06.009
015). Al-oﬁ (Al-Oﬁ et al., 2012), however, showed different
esults, i.e. they showed a decreased number of non-classical
onocytes in pregnant vs non-pregnant women and increased
umbers of classical monocytes in pregnant women, with no PRESS
ive Immunology xxx (2016) xxx–xxx 3
difference in intermediate monocytes. The reason for the differ-
ent outcomes between these studies may  be due to differences
in ﬂow cytometry methods, since in our studies (Melgert et al.,
2012; Groen et al., 2015) we  used whole blood for ﬂow cytome-
try, while Al-oﬁ isolated PBMC (Al-Oﬁ et al., 2012). As indicated
before, this latter method may  activate monocytes and thus poten-
tially change the ratio of monocyte subsets. The use of different
antibodies and different labels may  also explain differences in
outcome, while also gating strategy may  also have inﬂuenced out-
come.
2.2. Monocytes in rodent pregnancy
Rodents, like humans have a hemochorial placenta, indicat-
ing that in both species maternal immune cells are in direct
contact with fetal trophoblast. The rodent placenta, however, is
not identical to the human fetal placenta, since the rodent pla-
centa has a labyrinthine structure (Furukawa et al., 2014), rather
than a villous structure. Also the rodent placenta is hemotricho-
rial rather than hemomonochorial as in humans (Furukawa et al.,
2014). Moreover, the trophoblast facing the maternal blood space
is cytotrophoblast in rodents, rather than syncytiotrophoblast as in
humans (Furukawa et al., 2014). Rodents may  thus be useful mod-
els to study the (patho) physiological role of maternal peripheral
immune changes during pregnancy. Indeed, similar phenotypical
and functional activation of monocytes during pregnancy have
been observed in rats as compared with humans (Faas et al., 2000,
2004). These rat studies also showed that monocyte activation
gradually developed during pregnancy (Faas et al., 2000, 2004).
Unfortunately, although many studies have been done on immune
responses in pregnant mice, nothing is known about monocyte
activation in mouse pregnancy.
In rodents, like in humans, classical and non-classical mono-
cytes have been described (Ziegler-Heitbrock, 2015). Although the
functions of the subtypes are similar between humans and rodents,
rodent monocyte subtypes are not identiﬁed by CD14 and CD16
expression but by other markers: for rats, we use CD172a and
CD43 (Melgert et al., 2012), while for mice we use Ly6C (Elderman
et al., 2016). In rats, usually only 2 types of subsets are identi-
ﬁed, i.e. classical monocytes and non-classical monocytes (Melgert
et al., 2012; Ziegler-Heitbrock, 2015). Since intermediate mono-
cytes and non-classical monocytes have a relative similar gene
proﬁle (Wong et al., 2011), this may  suggest that the distinc-
tion between non-classical and intermediate monocytes cannot
be made in rats. In rats, we found decreased numbers of classi-
cal monocytes and increased numbers of non-classical monocytes
during pregnancy (Melgert et al., 2012; Groen et al., 2013). In line
with the above-mentioned data that the pro-inﬂammatory con-
dition in rat pregnancy develops gradually, we found that the
numbers of non-classical monocytes were increased as of day
13 of pregnancy (Melgert et al., 2012; Groen et al., 2013). In
mice, similar to humans, 3 subsets of monocytes can be identi-
ﬁed. We  recently showed that in syngeneic pregnant mice (both
BALB/c and B6 mice) numbers of intermediate monocytes are not
increased as compared to non-pregnant mice (Elderman et al.,
unpublished observations). Since both humans and our rat mod-
els carry allogeneic fetuses, this may suggest that allogeneity
is important for increasing the numbers of intermediate mono-
cytes.
2.3. How is monocyte activation and maturation induced during
pregnancy?nocytes in pregnancy and preeclampsia in humans and in rats. J.
The exact mechanisms by which pregnancy induces monocyte
activation and maturation are unknown. The placenta, however,
seems to play an important role (see Figs. 1 and 2 a). As periph-
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ral monocytes circulate through the placenta, they may  come into
irect contact with fetal syncytiotrophoblast, which may  activate
he monocytes. Indeed, in vitro studies have shown that mono-
ytes can adhere to syncytiotrophoblast cells (Xiao et al., 1997). As
any endothelial adhesion molecules are expressed on the syncy-
iotrophoblast (Dye et al., 2001), it seems likely that these adhesion
olecules are involved in the adherences of monocytes to the
yncytiotrophoblast. Indeed, adherence of monocytes to the syn-
ytiotrophoblast has been shown to be mediated by ICAM-1-LFA-1
nteractions (Xiao et al., 1997) or by fractaline (Siwetz et al., 2015).
uch interactions may  activate the monocytes, since it may  induce
he production of various pro-inﬂammatory cytokines (Butoi et al.,
011).
The fact that innate immune cells become activated after pas-
age through the placental circulation (Mellembakken et al., 2002)
ay  indeed suggest direct contact with the syncytiotrophoblast.
owever, it has also been shown that the syncytiotrophoblast
ecretes various factors into the maternal circulation, such as
ytokines (Sacks et al., 2001), fetal DNA (Bianchi et al., 1996). In vitro
tudies have indeed shown that factors present in the plasma
f pregnant women activate monocytes (Faas et al., 2010b). Also
lacental microparticles and exosomes are shed from the syncy-
iotrophoblast and may  activate the monocytes (Germain et al.,
007; Redman et al., 2012; Gohner et al., 2015; Mitchell et al.,
015). Future studies are necessary to evaluate the relative impor-
ance of direct and indirect monocyte-syncytiotrophoblast contact
n monocyte activation. Recently, it was shown that microparti-
les and exosomes not only activate monocytes but also induced
aturation of monocytes from classical monocytes towards inter-
ediate monocytes (Gohner et al., 2015). This may  suggest that
hese extracellular particles play a role in the monocyte activa-
ion and maturation during pregnancy. Not only particles shed from
he placenta, but also particles shed from other cells may  activate
onocytes (Sokolov et al., 2016).
. Monocytes in preeclampsia
Preeclampsia is a serious complication of pregnancy, character-
zed by hypertension and proteinuria developing in the second half
f pregnancy (Steegers et al., 2010). The ﬁrst stage of preeclamp-
ia is thought to be poor placentation or syncytiotrophoblast stress
Redman and Staff, 2015). The second stage is the production of pro-
nﬂammatory factors from the diseased placenta into the maternal
irculation, which further activate the inﬂammatory response,
ncluding monocytes and endothelial cells, ﬁnally resulting in the
igns of preeclampsia (Redman and Sargent, 2009).
It has now been well established that during preeclampsia,
he innate immune system is even further activated as compared
ith normal pregnancy (Borzychowski et al., 2006). Activation of
onocytes in preeclampsia has been demonstrated by increased
xpression of activation markers, such as CD11b, ICAM-1, CD14
nd TLR4 (Sacks et al., 1998; Gervasi et al., 2001; Mellembakken
t al., 2002; Luppi et al., 2006; Chen et al., 2015) as compared
ith healthy pregnancy. However, monocytes are not only phe-
otypically activated, they also produce increased amounts of
xygen free radicals as compared to normal pregnancy (Sacks
t al., 1998) and their cytokine production also differed as com-
ared to monocytes from normal pregnant women: The difference,
owever, may  depend on the method of measuring cytokine pro-
uction, as IL-12 and TNF were found to be increased (Sakai et al.,Please cite this article in press as: Faas, M.M.,  de Vos, P., Maternal mo
Reprod. Immunol. (2016), http://dx.doi.org/10.1016/j.jri.2016.06.009
002; Perac¸ oli et al., 2007; Brewster et al., 2008) or decreased
Veenstra Van Nieuwenhoven et al., 2008) in preeclampsia depend-
ng on the method used. The ﬁrst papers measured LPS stimulated
ytokine production using ELISA, while Veenstra van Nieuwen- PRESS
ive Immunology xxx (2016) xxx–xxx
hoven measured LPS stimulated cytokine production using ﬂow
cytometry.
3.1. Monocyte subsets in preeclampsia
As for normal pregnancy, the above mentioned studies did not
take into account the presence of monocyte subsets and thus mono-
cytes in the above mentioned studies are generally only deﬁned
using CD14. Recently, it was shown that numbers of intermediate
monocytes were even further increased and classical monocytes
further decreased in preeclampsia as compared with healthy preg-
nancy (Melgert et al., 2012). Although these data were in line with
data from Tang (Tang et al., 2015), Al-oﬁ showed increased numbers
of non-classical monocytes in preeclamptic women compared with
healthy pregnant women (Al-Oﬁ et al., 2012). As explained above,
this may  be due to different techniques used, but may  also be due to
a different selection of patient groups (inclusion of only early onset
preeclamptic women, vs inclusion of a more heterogeneous group
of preeclamptic women). Interestingly, Tang et al. showed that
numbers of intermediate monocytes correlated with the severity
of preeclampsia (Tang et al., 2015), suggesting that this monocyte
subset may  play a role in the pathogenesis of preeclampsia. Unfor-
tunately, it is unknown whether there is an increase in intermediate
monocyte before the onset of clinical signs of preeclampsia.
3.2. How is monocyte activation and maturation induced in
preeclampsia?
It seems likely that the placenta plays a major role in monocyte
activation and maturation during preeclampsia by direct contact
or by producing factors, which may  further activate and mature
monocytes (see Fig. 2b). During the second stage of preeclampsia,
the diseased placenta is thought to produce pro-inﬂammatory fac-
tors. In the peripheral circulation, many factors, which are able to
affect monocytes, were increased in preeclamptic vs healthy preg-
nant women. Such factors are for instance anti-angiogenic factors
(Maynard et al., 2003; Levine et al., 2004; Steinberg et al., 2009),
placental microparticles (Redman and Sargent, 2000; Gohner et al.,
2015) or ATP (Spaans et al., 2014d). The preeclamptic placenta has
also been shown to produce various pro-inﬂammatory cytokines,
such as TNF, IL-1ß, IL-18 (Wang and Walsh, 1996; Benyo et al.,
2001; Pang and Xing, 2003), with decreased production of anti-
inﬂammatory cytokines such as IL-10 (Hennessy et al., 1999; Rein
et al., 2003). These cytokines may  also be involved in activating
monocytes. Since monocytes themselves are also potent produc-
ers of cytokines, the activation of monocyte by placental factors
and cytokines may  in turn result in a vicious circle of monocytes
activation and cytokine production leading to persistent increased
monocyte activation, as well as activation of other immune cells,
such as granulocytes, NK cells and endothelial cells in preeclampsia
(Fig. 2b).
3.3. Monocytes in animal models for preeclampsia
As indicated above, due to the similarity in the fetal-maternal
contact in the placenta, rodents are useful models to study immune
responses in pregnancy. The advantage of the using the pregnant
rat above the pregnant mouse is the fact that the rat not only
has a hemochorial placenta, but the rat, and not the mouse, also
shows deep trophoblast invasion into the uterine wall (Vercruysse
et al., 2006; Soares et al., 2012; Spaans et al., 2014c). In accor-
dance with the suggestion that an activated inﬂammatory responsenocytes in pregnancy and preeclampsia in humans and in rats. J.
is part of the pathogenesis of preeclampsia, it has been shown in
rat that activation of monocytes during pregnancy, by for instance
LPS, ATP or TNF, induced preeclampsia-like signs (Faas et al.,
1994; LaMarca et al., 2008; Faas et al., 2010a). Such preeclampsia-
ARTICLE IN PRESSG ModelJRI-2420; No. of Pages 7
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Fig. 2. Schematic overview of the (patho) physiological role of monocyte subsets during healthy pregnancy (a) and pre-eclampsia (b).
During healthy pregnancy (a), the placenta, by direct contact and by producing soluble factors, activates monocyte subsets and induces increased maturation of classical
monocytes toward intermediate monocytes. Thee monocytes interact with other immune cells and endothelial cells. During pre-eclampsia (2b), more and other soluble
factors are produced from the diseased placenta, resulting in further activation of monocyte subsets and further maturation of classical monocytes toward intermediate
monocytes, resulting in an increased number of intermediate monocytes. Activated monocytes produce various (proinﬂammatory) cytokines. These cytokines further activate
the  monocytes as well as other immune cells and endothelial cells. This vicious circle of activation of monocytes, other immune cells and endothelial cells ﬁnally results in
the  symptoms of pre-eclampsia, such as hypertension and proteinuria.
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ike signs were not induced in identically treated non-pregnant
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4. Conclusion
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the diseased placenta. This may  induce further activation and mat-
uration of the monocytes, but may  also inﬂuence the other immune
cells and endothelial cells. Moreover, activated monocytes produce
cytokines, further activating the monocytes and other cells. This
 ING ModelJ
6 oduct
r
p
u
a
t
p
c
t
N
n
p
p
i
m
r
h
a
T
T
2
a
f
n
i
u
o
m
t
m
f
a
i
t
a
d
i
(
w
m
i
c
2
b
d
2
t
p
o
o
p
c
m
m
s
d
R
A
AARTICLERI-2420; No. of Pages 7
 M.M. Faas, P. de Vos / Journal of Repr
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016). Whether these cells arise from the blood monocyte popula-
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